ATHOLVILLE, New Brunswick--(BUSINESS WIRE)--Jul 30, 2018--Zenabis Ltd. (“Zenabis” or “the Company”), a New Brunswick-based licensed producer of cannabis, is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with the British Columbia Liquor Distribution Branch to supply cannabis to the British Columbia recreational market. The agreement strengthens the Company’s standing as one of Canada’s major cannabis suppliers.

“Our vision is to become a national supplier of high-quality cannabis products and to serve the needs of each province as we ramp up production,” says Kevin Coft, CEO of Zenabis. Over the next few months, Zenabis will be entering additional negotiations with other provinces.

With the British Columbia agreement in place, the Company will be hiring additional workers at its Atholville, New Brunswick facility. According to Coft, an additional 60 jobs will be posted over the next few weeks, effectively doubling the Company’s New Brunswick workforce.

“The BC agreement, together with our commitments to New Brunswick and Nova Scotia, is great news for the workforce and the community in Atholville,” says Coft. “We made a commitment to the Government of New Brunswick to increase the size of our operations as we entered into new agreements, and we are pleased to have delivered.”

More than 50 different varieties of cannabis products will be available to customers in each province. “The breadth and scope of our product line means that we will appeal to customers seeking both recreational and/or medical cannabis,” says Coft.

Legalization of recreational cannabis in Canada is effective October 17, 2018 and Zenabis products will be available in retail outlets throughout British Columbia, New Brunswick and Nova Scotia at that time.

About Zenabis Ltd.

Zenabis Ltd. is a privately-held, cannabis company with one of the largest, federally licensed indoor medical cultivation footprints in Canada. Zenabis currently operates two licensed production facilities in Surrey, British Columbia and Atholville, New Brunswick, with a third coming shortly in Nova Scotia. These facilities encompass 660,000 square feet of indoor pharmaceutical grade cannabis production space across Canada. Zenabis’ operations are strategically positioned on Canada’s coasts, facilitating national distribution and access to international markets. Zenabis is currently working towards globally recognized EU GMP (Good Manufacturing Practice) certifications.

Zenabis has one of the most experienced management teams in the industry, with an extensive background in retail consumer packaged goods, global pharmaceutical sales and manufacturing, quality assurance, and commercialized cultivation. Their growing team has decades of experience in organic cultivation and distribution of herbs and nutraceutical products throughout the Americas, North Africa and the Middle East. Their sales team has more than 20 years of experience in product development, commercialization, and retail and pharmaceutical sales including international distribution.

Join us on Facebook: https://www.facebook.com/zenabismmj/

Follow us on Twitter: @Zenabis

View source version on businesswire.com:https://www.businesswire.com/news/home/20180730005721/en/

CONTACT: Zenabis Ltd.

Media Contact:

Amanda LeBlanc, 506-333-8468

Revolution Strategy

amanda@revolutionstrategy.com

or

Gurdeep Bains

media@zenabis.com

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: OTHER CONSUMER TECHNOLOGY OTHER TECHNOLOGY HEALTH OTHER HEALTH RETAIL OTHER RETAIL CONSUMER GENERAL HEALTH

SOURCE: Zenabis Ltd.

Copyright Business Wire 2018.

PUB: 07/30/2018 03:09 PM/DISC: 07/30/2018 03:09 PM

http://www.businesswire.com/news/home/20180730005721/en